Your browser is no longer supported. Please, upgrade your browser.
OPGN OpGen, Inc. daily Stock Chart
OPGN [NASD]
OpGen, Inc.
Index- P/E- EPS (ttm)-0.78 Insider Own0.60% Shs Outstand52.75M Perf Week24.92%
Market Cap19.44M Forward P/E- EPS next Y-0.16 Insider Trans- Shs Float43.15M Perf Month36.48%
Income-18.80M PEG- EPS next Q-0.08 Inst Own25.50% Short Float9.14% Perf Quarter15.16%
Sales3.20M P/S6.07 EPS this Y21.30% Inst Trans48.17% Short Ratio1.97 Perf Half Y-65.88%
Book/sh0.02 P/B18.42 EPS next Y61.90% ROA-202.20% Target Price1.50 Perf Year-73.87%
Cash/sh0.03 P/C11.43 EPS next 5Y- ROE-522.80% 52W Range0.21 - 3.10 Perf YTD-67.96%
Dividend- P/FCF- EPS past 5Y- ROI-422.40% 52W High-88.11% Beta-
Dividend %- Quick Ratio0.50 Sales past 5Y- Gross Margin40.20% 52W Low73.82% ATR0.03
Employees59 Current Ratio0.60 Sales Q/Q-27.30% Oper. Margin- RSI (14)68.55 Volatility15.59% 11.67%
OptionableNo Debt/Eq2.17 EPS Q/Q40.60% Profit Margin- Rel Volume4.03 Prev Close0.32
ShortableYes LT Debt/Eq0.17 EarningsOct 23 AMC Payout- Avg Volume2.00M Price0.37
Recom2.00 SMA2022.40% SMA5028.75% SMA200-49.95% Volume8,077,025 Change15.37%
Jun-29-16Initiated Rodman & Renshaw Buy $2.50
Oct-13-17 07:30AM  OpGen to Present at Dawson James Securities 3rd Annual Small Cap Growth Conference GlobeNewswire
Oct-04-17 12:56PM  When Will OpGen Inc (OPGN) Run Out Of Money? Simply Wall St.
Oct-02-17 11:00AM  ETFs with exposure to OpGen, Inc. : October 2, 2017 Capital Cube
Sep-20-17 07:30AM  OpGen to Present at the Ladenburg Thalmann 2017 Healthcare Conference GlobeNewswire
Sep-19-17 06:16PM  ETFs with exposure to OpGen, Inc. : September 19, 2017 Capital Cube
Sep-18-17 01:21PM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q2, 2017 By the Numbers : September 18, 2017 Capital Cube
Sep-08-17 07:30AM  OpGen Data on New Rapid Gene Test and Antibiotic Susceptibility Prediction Algorithms Presented at the 2017 ASM/ESCMID Conference GlobeNewswire
Sep-06-17 09:00AM  OpGen to Present at the Rodman & Renshaw 19th Annual Global Investment Conference GlobeNewswire -6.61%
Aug-09-17 05:37PM  Edited Transcript of OPGN earnings conference call or presentation 8-Aug-17 8:30pm GMT Thomson Reuters StreetEvents -7.70%
Aug-08-17 04:01PM  OpGen Reports 2017 Second Quarter Financial Results and Provides Business Update GlobeNewswire
11:00AM  Investor Network: OpGen, Inc. to Host Earnings Call ACCESSWIRE
Aug-03-17 09:03PM  ETFs with exposure to OpGen, Inc. : August 4, 2017 Capital Cube -5.10%
Aug-02-17 07:30AM  OpGen Announces Date of Second Quarter 2017 Financial Results Conference Call GlobeNewswire
Jul-28-17 03:15PM  OpGen regains compliance with Nasdaq after public offering, but delisting threat remains American City Business Journals
Jul-19-17 09:25AM  OpGen Announces Closing of $10 Million Public Offering GlobeNewswire +5.96%
Jul-13-17 06:00AM  OpGen Announces Pricing of $10.0 Million Public Offering GlobeNewswire -23.58%
Jul-12-17 01:28PM  OpGen Acuitas® MDRO Gene Test Approved by NY State Department of Health GlobeNewswire -6.46%
Jun-19-17 08:00AM  OpGen Signs Supply Agreement to Use Thermo Fisher Scientifics Technology to Advance Acuitas® Rapid Test GlobeNewswire +6.78%
Jun-15-17 03:03PM  OpGens Acuitas® Detection Technology Utilized in Publication Revealing Prevalence of CRE in Washington D.C. Healthcare Facilities GlobeNewswire -5.82%
Jun-05-17 08:00AM  OpGen Data at ASM Microbe 2017 Demonstrates Potential of Acuitas Products for Predicting Antibiotic Susceptibility and Infection Control GlobeNewswire
May-30-17 08:00AM  OpGen to Receive Ignaz Semmelweis Award for Commitment to Combatting Infection Deaths GlobeNewswire
May-29-17 12:51PM  ETFs with exposure to OpGen, Inc. : May 29, 2017 Capital Cube
May-25-17 08:00AM  OpGen to Present Advancements in Antibiotic Susceptibility and Whole Genome Sequencing at ASM Microbe 2017 GlobeNewswire +37.02%
May-18-17 01:56PM  ETFs with exposure to OpGen, Inc. : May 18, 2017 Capital Cube -5.43%
May-05-17 04:26PM  ETFs with exposure to OpGen, Inc. : May 5, 2017 Capital Cube -11.36%
May-04-17 10:01AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 4, 2017 Capital Cube -5.77%
Apr-27-17 01:14PM  Edited Transcript of OPGN earnings conference call or presentation 26-Apr-17 8:30pm GMT Thomson Reuters StreetEvents -5.50%
08:00AM  OpGen Appoints Tina S. Nova, Ph.D. to Board of Directors GlobeNewswire
Apr-26-17 04:00PM  OpGen Announces 2017 First Quarter Financial Results GlobeNewswire
Apr-25-17 03:44PM  ETFs with exposure to OpGen, Inc. : April 25, 2017 Capital Cube +6.67%
08:00AM  OpGen Highlights Capabilities of its Acuitas® Technologies to Rapidly Predict Antibiotic Susceptibility Using Drug Resistance Gene Profiles at ECCMID GlobeNewswire
Apr-19-17 04:15PM  OpGen Announces Date of First Quarter 2017 Financial Results Conference Call GlobeNewswire
Apr-13-17 02:39PM  UPDATE -- OpGen to Present Antibiotic Resistance Prediction Data at 27th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) GlobeNewswire
Apr-12-17 04:30PM  OpGen to Present Antibiotic Resistance Prediction Data at 25th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) GlobeNewswire
Apr-05-17 05:14PM  ETFs with exposure to OpGen, Inc. : April 5, 2017 Capital Cube
Mar-30-17 01:04PM  OPGEN INC Financials
Mar-28-17 12:46PM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q4, 2016 By the Numbers : March 28, 2017 Capital Cube
10:33AM  OpGen, Inc. :OPGN-US: Earnings Analysis: 2016 By the Numbers : March 28, 2017
Mar-24-17 04:04PM  OPGEN INC Files SEC form 10-K, Annual Report
10:29AM  Edited Transcript of OPGN earnings conference call or presentation 23-Mar-17 8:30pm GMT Thomson Reuters StreetEvents
Mar-23-17 04:32PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Announces 2016 Fourth Quarter and Year End Financial Results GlobeNewswire
07:07AM  Q4 2016 OpGen Inc Earnings Release - After Market Close
Mar-01-17 08:00AM  OpGen to Present at the Cowen and Company 37th Annual Health Care Conference GlobeNewswire
Feb-15-17 11:29AM  Set Your Sights on This Infection-Fighting Biotech Company GuruFocus.com -5.31%
Feb-14-17 12:00PM  OpGen Presents Rapid Acuitas Genetic Test Data at Advances in Genome Biology and Technology Meeting GlobeNewswire
Jan-26-17 05:38PM  OpGen Reports Preliminary Fourth Quarter and Full Year 2016 Financial Results GlobeNewswire
04:54PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
Jan-17-17 08:00AM  OpGen Inc. Third Quarter 2016 Review and Fourth Quarter Earnings Outlook Accesswire -5.15%
Dec-19-16 03:30PM  OpGen Supports Passage of Landmark 21st Century Cures Act to Expedite Development of Solutions for Bacterial Infections GlobeNewswire -7.02%
Dec-16-16 04:23PM  OPGEN INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits +14.00%
09:26AM  OpGen Provides ATM Program Update GlobeNewswire
Nov-17-16 12:47PM  Heres What The OpGen Inc (OPGN) Merck & Co., Inc. (MRK) Agreement Really Means, And Why Its So Important at Insider Monkey
Nov-16-16 10:01AM  OPGEN INC Files SEC form 8-K, Regulation FD Disclosure
Nov-14-16 05:25PM  OpGen teams with Merck to fight superbugs at bizjournals.com
07:00AM  OpGen Collaborates With Merck to Develop Novel Rapid Diagnostics and Informatics Tools to Combat Antibiotic Resistance GlobeNewswire
06:13AM  OPGEN INC Files SEC form 10-Q, Quarterly Report
Oct-27-16 04:25PM  Large Integrated Health Outcomes Study Reveals Shifting Epidemiology In Drug Resistant Organisms GlobeNewswire -10.85%
Oct-26-16 08:00AM  OpGens Infectious Disease Portfolio Highlighted at IDWeek 2016 GlobeNewswire -5.83%
Oct-25-16 10:50AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q3, 2016 By the Numbers : October 25, 2016 -22.16%
10:12AM  Edited Transcript of OPGN earnings conference call or presentation 24-Oct-16 8:30pm GMT
Oct-24-16 04:33PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:01PM  OpGen Reports 2016 Third Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q3 2016 OpGen Inc Earnings Release - After Market Close
Oct-20-16 09:02AM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement
Oct-19-16 05:10PM  OpGen Announces Date of Third Quarter 2016 Financial Results Conference Call GlobeNewswire
Sep-14-16 05:26PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Sep-08-16 07:30AM  OpGen, Inc. to Host Anti-Infectives Roundtable at the World Anti-Microbial Resistance Congress GlobeNewswire
Sep-07-16 07:30AM  OpGen to Present at the Rodman & Renshaw 18th Annual Global Investment Conference GlobeNewswire
Sep-02-16 04:38PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
Aug-11-16 04:07PM  OPGEN INC Files SEC form 10-Q, Quarterly Report -13.06%
11:23AM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 11, 2016
Aug-10-16 03:22PM  Edited Transcript of OPGN earnings conference call or presentation 9-Aug-16 8:30pm GMT +6.73%
Aug-09-16 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
04:17PM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
04:02PM  OpGen Reports 2016 Second Quarter Financial Results and Provides Business Update GlobeNewswire
07:07AM  Q2 2016 OpGen Inc Earnings Release - Before Market Open
Aug-08-16 11:26AM  OpGen Announces Completion of the Intermountain Healthcare Retrospective MDRO Health Outcome Study GlobeNewswire
Aug-02-16 08:30AM  OpGen, Inc. Announces Timing for Second Quarter Financial Results and Conference Call GlobeNewswire
Jul-22-16 07:00AM  Why SFHI Could Follow Nintendo, OpGen or Liquidmetal In Unexpected Surge
Jul-20-16 04:12PM  Lack of Market Exposure Bothers Bulls +135.67%
Jul-19-16 01:15PM  Merck & Co., Inc. (MRK) and OpGen Inc (OPGN) Are Quietly Changing The Infectious Disease Landscape at Insider Monkey +12.23%
Jun-29-16 07:07AM  Coverage initiated on OpGen by Rodman & Renshaw
Jun-24-16 04:10PM  OPGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
Jun-20-16 12:30PM  OpGen Highlights Strong Performance of Acuitas® Resistome Test at ASM Microbe 2016 GlobeNewswire
Jun-06-16 05:04PM  OPGEN INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements a
12:11PM  OpGen, Inc. :OPGN-US: Earnings Analysis: Q1, 2016 By the Numbers : June 6, 2016
Jun-02-16 08:00AM  OpGen to Present at the 6th Annual LD Micro Invitational Conference Accesswire -5.39%
Jun-01-16 12:30PM  Merck & Co. venture arm backs superbug fighter OpGen in $10.3 million funding round at bizjournals.com -6.18%
May-26-16 09:35AM  Capital Infusions Are More Evidence of a Biotech Turnaround at 24/7 Wall St. -6.58%
May-20-16 04:14PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc. or Bylaws; C
10:14AM  OpGen Announces Closing of $10 Million Private Placement GlobeNewswire
May-18-16 06:52AM  Edited Transcript of OPGN earnings conference call or presentation 12-May-16 8:30pm GMT
May-17-16 05:28PM  OPGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits
09:00AM  OpGen Supports New White House National Microbiome Initiative GlobeNewswire
May-16-16 09:04AM  OPGEN INC Files SEC form 10-Q, Quarterly Report -7.89%
May-13-16 06:03AM  OPGEN INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits +10.68%
May-12-16 04:30PM  OpGen Inc Earnings Call scheduled for 4:30 pm ET today
OpGen, Inc., a precision medicine company, engages in developing molecular information products and services to combat infectious diseases in the healthcare industry worldwide. The company utilizes molecular diagnostics and bioinformatics to help combat infectious diseases. It also helps clinicians with information about life threatening infections, enhance patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms. The company's products include QuickFISH and PNA FISH products, which are FDA-cleared and CE-marked in vitro diagnostic tests designed to identify antimicrobial resistant pathogens, as well as XpressFISH diagnostic test products for the identification of various infectious pathogens. It also provides Acuitas MDRO Gene Test, Acuitas CR Elite Test, and Acuitas Resistome Test that are CLIA lab-based tests, which provide a profile of MDRO resistant genes for surveillance and response to outbreaks. In addition, the company offers Acuitas Lighthouse bioinformatics systems, which are cloud-based HIPAA compliant bioinformatics offerings that combine clinical lab test results with patient and hospital information, and provide analytics to enable manage MDROs in the hospital and patient care environment. Further, it engages in the development of Acuitas Rapid Test designed to detect the primary resistome profiles of gram negative organisms. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
jVen Capital, LLCChairman and CEOJul 18Buy0.401,875,000750,0005,680,604Jul 18 04:22 PM
DEC TIMOTHY CChief Financial OfficerJul 18Buy0.4065,00026,000118,966Jul 18 04:10 PM